Saturday 26 April 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Repertoire Immune Medicines
A clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases.
Pharmaceutical
Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk
28 March 2025
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024

Latest Ones To Watch News

Pharmaceutical
Guardant Health and Pfizer team up
25 April 2025
Biotechnology
LTZ bags $40 million as it sends first myeloid engager into clinic
25 April 2025
Biotechnology
$100 million gives Granite solid foundation for autoimmune work
25 April 2025
More ones to watch news >
Reset all filters
Refine Search
Halda Therapeutics
Halda Therapeutics
Opthea
Opthea
OncoZenge
Axsome Therapeutics
Soleno Therapeutics
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics


Today's issue

AbbVie arrows upwards on upgraded earnings estimate
Pharmaceutical
AbbVie arrows upwards on upgraded earnings estimate
25 April 2025
Biotechnology
New EC nod for J&J’s Tremfya
25 April 2025
Pharmaceutical
Guardant Health and Pfizer team up
25 April 2025
Biotechnology
LTZ bags $40 million as it sends first myeloid engager into clinic
25 April 2025
Pharmaceutical
Industry-backed study highlights value of antibiotic R&D incentive
25 April 2025
Biotechnology
Halozyme files lawsuit against Merck over SC Keytruda
25 April 2025
Pharmaceutical
Convatec to launch nitric oxide product as analysts highlight resilience
25 April 2025

Company Spotlight

A clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze